Replies to post #116195 on NanoViricides Inc. (NNVC)

[Nanotoday]

NNVC had and equal amount in the bank when it did the initial RS and when it took the money from Dr. B. as well as other dilutive loans (remember Seaside)? And made similar claims to "having sufficient funds" and then took additional loans and the RS. I know they explained the reasoning for the RS, but honestly, NONE of the benefits they claimed would come from the RS have come to fruition. And I have to believe they were not expecting it to impact the SP as dramatically as it did. We are now BELOW where it was prior to the RS. And I don't mean as a factor of 3.5, I mean the SP was $1.36 and then they spilt and everyone got diluted 3.5 to 1 and now the SP is $1.20 AFTER the split (or .40 pre split) a decrease of…300%!

There was talk of always wanting to have a year of operating in the bank, but honestly I don't recall if that was a company position or a claim that it was an FCC requirement (I think if the latter, it is not correct).

If the former is correct, then they would be looking for additional funding in just over 12 months.

Just saying the company has NEVER waited until it actually needed funding, or was even close, when they've taken additional funding. And the company has always preceded any additional funding with statements saying they do not and would not take funding.

Those are facts.

[JG36]

A $3M burn rate means NNVC has 9 quarters left before it is out of money. But it must raise funds well before it reaches that point. So NNVC will have to raise money (in the usual fashion, by selling stock) within a year or so. Phase 1 will not be complete by then, so the stock price at which NNVC must raise funds well be based upon whether tox is done by then (and of course, what the results of tox are by then). My most optimistic view is that the stock price will be well south of $3, and quite likely south of $2, when the next big stock dilution takes place. It won't be pretty. Of course if NNVC proceeds in its usual fashion the stock price could easily be below a buck by then.

It's also possible that with no clinical trials underway when the next big round of financing comes up that the market will just stay away entirely, and NNVC goes belly up.

[Rawnoc]

MORE DILUTION COMING: drkaz -- the 10Q calls bullshit:

"While we now have the necessary funds based on our current operations to last more than the next 24 months, we anticipate undertaking additional expenditures to accelerate our progress to regulatory submissions."

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10998033